Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2025-12-24 @ 10:55 PM
NCT ID:
NCT06468969
Eligibility Criteria:
Inclusion Criteria:
* Age: 18 to 72 years at the time of informed consent.
* Underwent radical total gastrectomy.
* Postoperative pathology confirmed advanced adenocarcinoma of the stomach or gastroesophageal junction.
* Estimated survival time ≥3 months.
* Good cognitive and reading abilities, capable of completing questionnaires.
* Willing and able to provide written informed consent for the study.
Exclusion Criteria:
* Participation in another clinical trial within 4 weeks prior to enrollment.
* Patients with other malignancies.
* Clinically significant cardiovascular disease, such as heart failure (NYHA III-IV), uncontrolled coronary artery disease, cardiomyopathy, arrhythmia, or hypertension.
* Neurological or psychiatric disorders affecting cognitive function, including central nervous system metastasis.
* Active infectious diseases, such as active hepatitis or tuberculosis.
* Uncontrolled systemic diseases, such as poorly controlled diabetes.
* Interstitial lung disease, such as interstitial pneumonia, pulmonary fibrosis, or evidence of interstitial lung disease on baseline chest X-ray/CT.
* Pregnant or breastfeeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
72 Years
Study:
NCT06468969
Study Brief:
Protocol Section:
NCT06468969